Literature DB >> 4240

Creatine kinase in serum: 1. Determination of optimum reaction conditions.

G Szasz, W Gruber, E Bernt.   

Abstract

To establish optimum conditions for creatine kinase (EC 2.7.3.2) activity measurement with the creatine phosphate in equilibrium creatine reaction, we re-examined all kinetics factors relevant to an optimal and standardized enzyme assay at 30 and 25 degrees C. We determined the pH optimum in vaious buffers, considering the effect of the type and concentration of the buffer, as well as the influence of various buffer anions on the activity. The relation between activity and substrate concentration was shown and the apparent Michaelis constants of creatine kinase for creatine phosphate and ADP were evaluated. We tested the effect on creatine kinase measurement of the concentration of substrates (glucose and NADP+) in the auxillary and indicator reactions, especially the influence of the added auxiliary (hexokinase) and indicator (glucose-6-phosphate dehydrogenase) enzymes on the lag phase, at different temperatures. The NADP+ concentration proved to be the factor limiting the duration of constant reaction rate. We studied the inhibition of creatine kinase and adenylate kinase by AMP and established a convenient AMP concentration. For reactivation of creatine kinase, N-acetyl cysteine as sulfhydryl compound was introduced. Finally, we examined the relationship between activity and temperature.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 4240

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  70 in total

1.  Effects of repeated brief episodes of ischemia and reperfusion in isolated perfused rat hearts.

Authors:  T Yasumura; N Aoki; A Yanagisawa; A Maki; C Shirato; K Ishikawa
Journal:  Heart Vessels       Date:  1999       Impact factor: 2.037

2.  Enhanced myogenic differentiation by extracellular matrix is regulated at the early stages of myogenesis.

Authors:  Ramon C J Langen; Annemie M W J Schols; Marco C J M Kelders; Emiel F M Wouters; Yvonne M W Janssen-Heininger
Journal:  In Vitro Cell Dev Biol Anim       Date:  2003 Mar-Apr       Impact factor: 2.416

3.  The MRL +/+ mouse: a new model of tubular aggregates which are gender- and age-related.

Authors:  R W Kuncl; A Pestronk; J Lane; E Alexander
Journal:  Acta Neuropathol       Date:  1989       Impact factor: 17.088

4.  Clinical chemistry through Clinical Chemistry: a journal timeline.

Authors:  Robert Rej
Journal:  Clin Chem       Date:  2004-12       Impact factor: 8.327

5.  Prevalence of macrocreatinkinase type 1 in patients with inflammatory bowel disease.

Authors:  J L Perez-Calle; I Marin-Jimenez; P Lopez-Serrano; J P Gisbert; A S Pena; C Fernandez-Rodriguez
Journal:  Dig Dis Sci       Date:  2007-06-28       Impact factor: 3.199

6.  Exercise-induced muscle damage: effects of light exercise on damaged muscle.

Authors:  A E Donnelly; P M Clarkson; R J Maughan
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1992

7.  Human 'creatine kinase conversion factor' identified as a carboxypeptidase.

Authors:  R J Edwards; D C Watts
Journal:  Biochem J       Date:  1984-07-15       Impact factor: 3.857

8.  Dietary fish oil and vitamin E enhance doxorubicin effects in P388 tumor-bearing mice.

Authors:  Qi-Yuan Liu; Benny K H Tan
Journal:  Lipids       Date:  2002-06       Impact factor: 1.880

9.  Effect of dietary lipids on the lipid composition and phospholipid deacylating enzyme activities of rat heart.

Authors:  J Leonardi; E Termine; F Morand; R Lafont; H Portugal; H Lafont; G Nalbone
Journal:  Lipids       Date:  1987-07       Impact factor: 1.880

10.  Creatine kinase activity in the Torpedo electrocyte and in the nonreceptor, peripheral v proteins from acetylcholine receptor-rich membranes.

Authors:  F J Barrantes; G Mieskes; T Wallimann
Journal:  Proc Natl Acad Sci U S A       Date:  1983-09       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.